文献速递腹部技术与安全USCT

预测肝细胞癌患者症状性肝切除术后肝衰竭:术前列线图的开发与验证

Predicting symptomatic post-hepatectomy liver failure in patients with hepatocellular carcinoma: development and validation of a preoperative nomogram.
PubMed 文献 · Eur Radiol · 2023-06-14

前瞻性纳入三家三级转诊医院266例肝细胞癌患者,术前用二维剪切波弹性成像测肝硬度,结合三维虚拟切除所得未来肝残余体积比、Child-Pugh分级和临床显著门脉高压构建列线图,用于预测症状性肝切除术后肝衰竭;推导队列AUC 0.915,内部验证AUC 0.876,外部验证AUC 0.845,校准良好,并据此分层未来肝残余体积比的安全界限。

要点

  • 肝硬度>9.5 kPa与肝细胞癌患者症状性肝切除术后肝衰竭发生相关。
  • 列线图整合肝硬度、Child-Pugh分级、临床显著门脉高压和未来肝残余体积比。
  • 推导队列AUC 0.915、内部验证0.876、外部验证0.845,校准良好。

核心结论

  • 肝硬度升高与肝细胞癌患者症状性肝切除术后肝衰竭的发生相关;整合肝硬度、临床和体积特征的术前列线图有助于预测肝细胞癌患者术后结局,可能帮助外科医生管理肝细胞癌切除。

研究设计与样本

  • 前瞻性研究,2018年8月至2021年4月从三家三级转诊医院纳入266例肝细胞癌患者;术前实验室检查获取肝功能参数,二维剪切波弹性成像测量肝硬度,三维虚拟切除获取包括未来肝残余在内的不同体积;用逻辑回归开发列线图,经受试者工作特征曲线和校准曲线分析确定,并进行内部和外部验证。

诊断标准与关键数值

  • 列线图变量包括未来肝残余体积比(未来肝残余体积占总肝体积的比例)、肝硬度>9.5 kPa、Child-Pugh分级和临床显著门脉高压的存在;推导队列AUC 0.915,内部五折交叉验证平均AUC 0.918,内部验证队列AUC 0.876,外部验证队列AUC 0.845;推导、内部验证和外部验证队列的Hosmer-Lemeshow拟合优度检验p值分别为0.641、0.06和0.127;据此用列线图对未来肝残余体积比的安全界限进行分层。

临床应用与阅片要点

  • 术前可测量肝硬度(最佳截断值9.5 kPa)、Child-Pugh分级、临床显著门脉高压和未来肝残余体积比,用该列线图预测症状性肝切除术后肝衰竭,并参考其分层的未来肝残余体积比安全界限辅助手术管理。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To develop and validate a nomogram based on liver stiffness (LS) for predicting symptomatic post-hepatectomy (PHLF) in patients with hepatocellular carcinoma (HCC).

METHODS: A total of 266 patients with HCC were enrolled prospectively from three tertiary referral hospitals from August 2018 to April 2021. All patients underwent preoperative laboratory examination to obtain parameters of liver function. Two-dimensional shear wave elastography (2D-SWE) was performed to measure LS. Three-dimensional virtual resection obtained the different volumes including future liver remnant (FLR). A nomogram was developed by using logistic regression and determined by receiver operating characteristic (ROC) curve analysis and calibration curve analysis, which was validated internally and externally.

RESULTS: A nomogram was constructed with the following variables: FLR ratio (FLR of total liver volume), LS greater than 9.5 kPa, Child-Pugh grade, and the presence of clinically significant portal hypertension (CSPH). This nomogram enabled differentiation of symptomatic PHLF in the derivation cohort (area under curve [AUC], 0.915), internal fivefold cross-validation (mean AUC, 0.918), internal validation cohort (AUC, 0.876) and external validation cohort (AUC, 0.845). The nomogram also showed good calibration in the derivation, internal validation, and external validation cohorts (Hosmer-Lemeshow goodness-of-fit test, p = 0.641, p = 0.06, and p = 0.127, respectively). Accordingly, the safe limit of the FLR ratio was stratified using the nomogram.

CONCLUSION: An elevated level of LS was associated with the occurrence of symptomatic PHLF in HCC. A preoperative nomogram integrating LS, clinical and volumetric features was useful in predicting postoperative outcomes in patients with HCC, which might help surgeons in the management of HCC resection.

CLINICAL RELEVANCE STATEMENT: A serial of the safe limit of the future liver remnant was proposed by a preoperative nomogram for hepatocellular carcinoma, which might help surgeons in 'how much remnant is enough in liver resection'.

KEY POINTS: • An elevated liver stiffness with the best cutoff value of 9.5 kPa was associated with the occurrence of symptomatic post-hepatectomy liver failure in hepatocellular carcinoma. • A nomogram based on both quality (Child-Pugh grade, liver stiffness, and portal hypertension) and quantity of future liver remnant was developed to predict symptomatic post-hepatectomy liver failure for HCC, which enabled good discrimination and calibration in both derivation and validation cohorts. • The safe limit of future liver remnant volume was stratified using the proposed nomogram, which might help surgeons in the management of HCC resection.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Long, Peng, Ding, et al. Predicting symptomatic post-hepatectomy liver failure in patients with hepatocellular carcinoma: development and validation of a preoperative nomogram. Eur Radiol. 2023. PMID: 37314474. doi:10.1007/s00330-023-09803-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。